Sponsor Pipeline

Prilenia Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Phase 3
2
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-08 NCT07609108
Pridopidine Phase 3 Study in Huntington's Disease		 Recruitment opened
2026-08-08 NCT07609108
Pridopidine Phase 3 Study in Huntington's Disease		 Trial sites expanded: 0 -> 66 locations
2026-07-30 NCT07322003
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS		 Trial sites expanded: 47 -> 56 locations
2026-07-29 NCT07322003
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS		 Trial sites expanded: 44 -> 47 locations
2026-07-24 NCT07322003
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS		 Trial sites expanded: 36 -> 44 locations
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07609108 Pridopidine Phase 3 Study in Huntington's Disease Huntington Disease Recruiting
NCT07322003 Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS Amyotrophic Lateral Sclerosis Recruiting
Disease Areas
ALS (1) Huntington's Disease (1)
Get alerts when Prilenia's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free